Avalo Therapeutics Share Price (NASDAQ: AVTX)
$9.21
Last updated on
Check the interactive Avalo Therapeutics Stock chart to analyse performance
Avalo Therapeutics stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$9.10Today's High:$9.46
1.19%
Downside
Day's Volatility :3.75%
Upside
2.59%
- 52 Weeks Low:$3.3952 Weeks High:$16.00
63.19%
Downside
52 Weeks Volatility :78.81%
Upside
42.44%
Avalo Therapeutics Stock Returns
Avalo Therapeutics Inc Key Stats
Check Avalo Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Avalo Therapeutics Stock including INR - Dollar returns
The Avalo Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Avalo Therapeutics investment value today
Current value as on today
₹1,21,719
Returns
₹21,719
(+21.72%)
Returns from Avalo Therapeutics Stock
₹16,435 (+16.43%)
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Avalo Therapeutics Stock
Global Institutional Holdings in Avalo Therapeutics Inc
Name
Holdings %
Bvf Inc
9.49%
Nantahala Capital Management, LLC
9.18%
Orbimed Advisors, LLC
8.92%
RA Capital Management, LLC
8.61%
Affinity Asset Advisors, LLC
6.06%
Deep Track Capital, LP
5.23%
Analyst Recommendation on Avalo Therapeutics Stock
Sell
0%Buy
50%Hold
50%Sell
Based on 6 Wall street analysts offering stock ratings for Avalo Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Avalo Therapeutics Share Price Target
What analysts predicted
Upside of 235.04%
Target:
$30.86
Current:
$9.21
Avalo Therapeutics share price target is $30.86, a slight Upside of 235.04% compared to current price of $9.21 as per analysts' prediction.
Avalo Therapeutics Stock Insights
Price Movement
In the last 7 days, AVTX stock has moved down by -7.9%Decreasing Revenue
Revenue is down for the last 3 quarters, 571.0K → 192.0K (in $), with an average decrease of 39.6% per quarterDecreasing Net Profit
Netprofit is down for the last 2 quarters, -13.14M → -20.76M (in $), with an average decrease of 57.9% per quarterAVTX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 39.9%AVTX vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 211.8%Price to Sales
ForAVTX every $1 of sales, investors are willing to pay $193.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Avalo Therapeutics Technicals Summary
Sell
Neutral
Buy
Avalo Therapeutics is currently in a neutral trading position according to technical analysis indicators.
Avalo Therapeutics Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 15.34% | 35.82% | 15.04% | -99.19% | -99.89% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| 1.43 | 1.43 | NA | -6.01 | -0.9 | -0.32 | NA | 9.65 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Sell | $122.8M | -99.89% | 1.43 | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Avalo Therapeutics Inc
Key Management of Avalo Therapeutics Inc
Important FAQs about investing in AVTX Stock from India :
What is Avalo Therapeutics share price today?
Avalo Therapeutics share price today is $9.21 as on at the close of the market. Avalo Therapeutics share today touched a day high of $9.46 and a low of $9.10.
What is the 52 week high and 52 week low for Avalo Therapeutics share?
Avalo Therapeutics share touched a 52 week high of $16.00 and a 52 week low of $3.39. Avalo Therapeutics stock price today i.e. is closed at $9.21, lower by 42.44% versus the 52 week high.
How to invest in Avalo Therapeutics Stock (AVTX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Avalo Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Avalo Therapeutics Shares that will get you 0.1629 shares as per Avalo Therapeutics share price of $9.21 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Avalo Therapeutics Stock (AVTX) from India?
Indian investors can start investing in Avalo Therapeutics (AVTX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Avalo Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Avalo Therapeutics share’s latest price of $9.21 as on August 30, 2025 at 1:29 am IST, you will get 1.0858 shares of Avalo Therapeutics. Learn more about
fractional shares .
What are the returns that Avalo Therapeutics has given to Indian investors in the last 5 years?
Avalo Therapeutics stock has given -99.89% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
- Cambria Value And Momentum Etf
$32.55
+0.25%